当前位置： SCI文献检索 > CANCER BIOLOGY & THERAPY期刊下所有文献 > Increased frequency of circulating invariant natural killer T cells in malignant pleural mesothelioma patients.

Increased frequency of circulating invariant natural killer T cells in malignant pleural mesothelioma patients.

Abstract：

:Invariant natural killer T (iNKT) cells are a distinct subset of human T cells, which expresses an invariant T cell receptor Vα24 Jα18 and recognizes glycolipid antigens in the context of CD1d molecules. iNKT cells exert pivotal regulatory roles in many immune responses, including antitumor immune responses. Alterations in iNKT cell frequency, phenotype, and activation state have been reported in cancer patients. No data are available on the iNKT cells in malignant pleural mesothelioma (MPM), a rare, but very aggressive, malignancy of the pleura with a very poor prognosis. Here, we studied the frequency, phenotype, and cytokine profile of circulating iNKT cells in MPM patients, and correlated results with tumor histological types (epithelioid, sarcomatoid, biphasic) and clinical stages (I-III). We found that the iNKT cell frequency was significantly increased in MPM patients with epithelioid and sarcomatoid types in comparison with healthy volunteers (HV); only three biphasic mesotheliomas were available in this study, thus no conclusions can be drawn for this MPM type. The increased frequency significantly correlates with the clinical stage of tumor with the highest value at the stage III in both epithelioid and sarcomatoid subtypes. According to the histological types, we measured changes in the frequencies of CD4⁺ CD8⁺ (DP) and CD4⁻CD8⁻ (DN), but not in the cytokine profiles (IFN-γ/IL-4 expression). These results demonstrate that the frequency of iNKT cells is increased in MPM patients and that this increase correlates with MPM type and stage.

journal_name

Cancer Biol Ther

journal_title

Cancer biology & therapy

authors

Altomare E,Fallarini S,Biaggi G,Gattoni E,Botta M,Lombardi G

doi

10.4161/cbt.20553

subject

Has Abstract

pub_date

2012-07-01 00:00:00

pages

702-11

issue

9

eissn

1538-4047

issn

1555-8576

pii

20553

journal_volume

13

pub_type

杂志文章

相关文献

CANCER BIOLOGY & THERAPY文献大全
  • FGFR genes mutation is an independent prognostic factor and associated with lymph node metastasis in squamous non-small cell lung cancer.

    abstract：:Targeting FGFRs is one of the most promising therapeutic strategies in squamous non-small cell lung cancer (SQCC). However, different FGFR genomic aberrations can be associated with distinct biological characteristics that result in different clinical outcomes or therapeutic consequences. Currently, the full spectrum ...

    journal_title：Cancer biology & therapy

    pub_type： 杂志文章

    doi：10.1080/15384047.2018.1480294

    authors： Li JJ,Yan S,Pan Y,Liu Z,Liu Y,Deng Q,Tan Q,Woodward ER,Wu N

    更新日期：2018-01-01 00:00:00

  • Kmt2a cooperates with menin to suppress tumorigenesis in mouse pancreatic islets.

    abstract：:The reported incidence of pancreatic neuroendocrine tumors (PanNETs) has increased, due in large part to improvements in detection and awareness. However, therapeutic options are limited and a critical need exists for understanding a more thorough characterization of the molecular pathology underlying this disease. Th...

    journal_title：Cancer biology & therapy

    pub_type： 杂志文章

    doi：10.1080/15384047.2016.1250986

    authors： Lin W,Francis JM,Li H,Gao X,Pedamallu CS,Ernst P,Meyerson M

    更新日期：2016-12-01 00:00:00

  • New strategy for efficient selection of dendritic cell-tumor hybrids and clonal heterogeneity of resulting hybrids.

    abstract：:Heterotypic hybrids created between dendritic cells (DC) and tumor cells represent an efficient approach for loading DC with tumor-associated antigens (TAA) and DC-tumor hybrid vaccines have shown promising outcomes in various preclinical and clinical studies. Conventional DC-tumor hybrid preparations, however, are un...

    journal_title：Cancer biology & therapy

    pub_type： 杂志文章

    doi：10.4161/cbt.3.11.1217

    authors： Matsue H,Matsue K,Edelbaum D,Walters M,Morita A,Takashima A

    更新日期：2004-11-01 00:00:00

  • Adenovirus-mediated Ink4a/ARF gene transfer significantly suppressed the growth of pancreatic carcinoma cells.

    abstract：OBJECTIVES:To determine the effects of adenovirus-mediated transfer of p14(ARF) and p16(INK4a) on growth and apoptosis of human pancreatic carcinoma cell lines. RESULTS:Pancreatic carcinoma cell lines, PC-7, PANC-1 and MIA PaCa-2 (p14(ARF)-/- and p16(INK4a)-/-), were used. PC-7 (p53 wt) and MIA PaCa-2 (p53 mt) cells i...

    journal_title：Cancer biology & therapy

    pub_type： 杂志文章

    doi：10.4161/cbt.4.12.2183

    authors： Chen F,Li Y,Lu Z,Gao J,Chen J

    更新日期：2005-12-01 00:00:00

  • KLF4 and PCNA identify stages of tumor initiation in a conditional model of cutaneous squamous epithelial neoplasia.

    abstract：:KLF4 is induced upon growth-arrest in vitro and during epithelial maturation in vivo, and is essential for proper cell fate specification of post-mitotic cells. In spite of a normal role in post-mitotic cells, expression is upregulated and constitutive in certain tumor types. KLF4 functions as an oncogene in vitro, an...

    journal_title：Cancer biology & therapy

    pub_type： 杂志文章

    doi：10.4161/cbt.4.12.2355

    authors： Huang CC,Liu Z,Li X,Bailey SK,Nail CD,Foster KW,Frost AR,Ruppert JM,Lobo-Ruppert SM

    更新日期：2005-12-01 00:00:00

  • CIP2A expression and localization in oral carcinoma and dysplasia.

    abstract：AIMS:Oral squamous cell carcinoma (OSCC) is the most prevalent malignancy of the oral cavity resulting in severe morbidity and mortality. To date only few proteins have been suggested as potential biomarkers or targets for this type of cancer. Cancerous inhibitor of PP2A (CIP2A) is a protein expressed in epithelial tis...

    journal_title：Cancer biology & therapy

    pub_type： 评论,杂志文章

    doi：10.4161/cbt.10.7.12895

    authors： Katz J,Jakymiw A,Ducksworth MK,Stewart CM,Bhattacharyya I,Cha S,Chan EK

    更新日期：2010-10-01 00:00:00

  • Multiplying therapies and reducing toxicity in metastatic melanoma.

    abstract：:Prior to 2011, only 2 systemic treatments were approved for the treatment of melanoma and these had limited efficacy. In the past 4 years, 6 novel agents have received FDA approval. Herein, we will focus on 4 recently published NEJM papers reporting the results of clinical trials, comprising 4 agents targeting the MAP...

    journal_title：Cancer biology & therapy

    pub_type： 杂志文章

    doi：10.1080/15384047.2015.1046650

    authors： Massey PR,Prasad V,Figg WD,Fojo T

    更新日期：2015-01-01 00:00:00

  • In vivo long-term imaging and radioiodine therapy by sodium-iodide symporter gene expression using a lentiviral system containing ubiquitin C promoter.

    abstract：:To establish stable and long-term gene expression in vitro and in vivo, we developed a lentiviral vector system carrying sodium iodide symporter (hNIS) gene under UbC promoter, and transfected this into a colon cancer cell line. The in vitro and in vivo kinetics of radioiodine and [99mTc]-pertechnetate were then inves...

    journal_title：Cancer biology & therapy

    pub_type： 杂志文章

    doi：10.4161/cbt.6.7.4342

    authors： Kim HJ,Jeon YH,Kang JH,Lee YJ,Kim KI,Chung HK,Jeong JM,Lee DS,Lee MC,Chung JK

    更新日期：2007-07-01 00:00:00

  • Molecular basis of pathogenesis, prognosis and therapy in chronic lymphocytic leukaemia.

    abstract：:B-cell chronic lymphocytic leukemia (CLL) is caused by the abnormal accumulation of non-functional B-cells in peripheral blood and bone marrow. However, the precise aetiology and mechanism of the disease are unclear. Recently, progress has been made in the identification of both the genetic deficiencies and environmen...

    journal_title：Cancer biology & therapy

    pub_type： 杂志文章,评审

    doi：10.4161/cbt.7.2.5262

    authors： Chen J,McMillan NA

    更新日期：2008-02-01 00:00:00

  • mRNA expression profile of multidrug-resistant genes in acute lymphoblastic leukemia of children, a prognostic value for ABCA3 and ABCA2.

    abstract：:Multidrug resistance (MDR) is an important cause of treatment failure in acute lymphoblastic leukemia (ALL). The ABC family of membrane transporters is proposed, albeit with controversy, to be involved in this process. The present study aims to investigate the mRNA expression profile of several genes of this family, i...

    journal_title：Cancer biology & therapy

    pub_type： 杂志文章

    doi：10.4161/cbt.26603

    authors： Rahgozar S,Moafi A,Abedi M,Entezar-E-Ghaem M,Moshtaghian J,Ghaedi K,Esmaeili A,Montazeri F

    更新日期：2014-01-01 00:00:00

  • Dissecting the roles of E1A and E1B in adenoviral replication and RCAd-enhanced RDAd transduction efficacy on tumor cells.

    abstract：:Oncolytic viruses have recently received widespread attention for their potential in innovative cancer therapy. Many telomerase promoter-regulated oncolytic adenoviral vectors retain E1A and E1B. However, the functions of E1A and E1B proteins in the oncolytic role of replication-competent adenovirus (RCAd) and RCAd en...

    journal_title：Cancer biology & therapy

    pub_type： 杂志文章

    doi：10.4161/cbt.29842

    authors： Wei F,Wang H,Chen X,Li C,Huang Q

    更新日期：2014-10-01 00:00:00

  • Epigenetic changes activate widespread signals in response to double-strand breaks.

    abstract：:Double-strand breaks are one the most severe types of DNA damage with respect to cell survival and the preservation of genomic integrity. Therefore, cells have evolved complex mechanisms including cell cycle regulation, activation of repair pathways and in certain cases induction of apoptosis in response to these lesi...

    journal_title：Cancer biology & therapy

    pub_type： 杂志文章,评审

    doi：10.4161/cbt.3.7.917

    authors： Karagiannis TC,El-Osta A

    更新日期：2004-07-01 00:00:00

  • Nucleophosmin/B23, a multifunctional protein that can regulate apoptosis.

    abstract：:Nucleophosmin (NPM)/B23, a multifunctional nucleolar protein, is overexpressed in actively proliferating cells and cancer cells. B23 is a tumor marker and exerts its oncogenic effect through binding and suppressing numerous tumor suppressors. NPM-ALK, an aberrant fusion protein produced from t(2;5) translocation in an...

    journal_title：Cancer biology & therapy

    pub_type： 杂志文章,评审

    doi：10.4161/cbt.4.9.2072

    authors： Ye K

    更新日期：2005-09-01 00:00:00

  • 17beta-estradiol and tamoxifen stimulate rapid and transient ERK activationin MCF-7 cells via distinct signaling mechanisms.

    abstract：:Traditionally, estrogen signaling was thought to be mediated strictly through genomic pathways. Recently, however, it has been demonstrated that estrogen stimulation of cells leads to rapid nongenomic effects including ERK activation. While the precise mechanism of this action is still under investigation, it is known...

    journal_title：Cancer biology & therapy

    pub_type： 杂志文章

    doi：10.4161/cbt.5.12.3378

    authors： Visram H,Greer PA

    更新日期：2006-12-01 00:00:00

  • Invasive stratified mucin-producing carcinoma: a clinicopathological analysis of three cases.

    abstract：:Objective: To investigate the clinicopathologic features and immunophenotype of invasive-stratified mucin-producing carcinoma (ISMC). Methods: We retrospectively analyzed three patients who underwent surgery for pathologically confirmed ISMC from January 2017 to December 2017 in Anyang Tumor Hospital. The pathological...

    journal_title：Cancer biology & therapy

    pub_type： 杂志文章

    doi：10.1080/15384047.2019.1647054

    authors： Lei R

    更新日期：2019-01-01 00:00:00

  • Fingolimod augments Pemetrexed killing of non-small cell lung cancer and overcomes resistance to ERBB inhibition.

    abstract：:Overall, NSCLC has a poor 5-year survival and new therapeutic approaches are urgently needed. ERBB-addicted NSCLC that have become resistant to ERBB inhibitors are often refractory to additional therapeutic interventions. The sphingosine-1-phosphate receptor modulator fingolimod (FTY720), approved for the treatment of...

    journal_title：Cancer biology & therapy

    pub_type： 杂志文章

    doi：10.1080/15384047.2018.1538616

    authors： Booth L,Roberts JL,Spiegel S,Poklepovic A,Dent P

    更新日期：2019-01-01 00:00:00

  • Remarkable enhancement of cytotoxicity of onconase and cepharanthine when used in combination on various tumor cell lines.

    abstract：:Onconase (Onc), a ribonuclease from oocytes or early embryos of Northern Leopard frog (Rana pipiens), is cytostatic and cytotoxic to a variety of tumor lines in vitro, inhibits growth of tumors in animal in vivo models and is currently in Phase IIIb clinical trials for malignant mesothelioma where it displays antitumo...

    journal_title：Cancer biology & therapy

    pub_type： 杂志文章

    doi：10.4161/cbt.7.7.6172

    authors： Ita M,Halicka HD,Tanaka T,Kurose A,Ardelt B,Shogen K,Darzynkiewicz Z

    更新日期：2008-07-01 00:00:00

  • A prospective comparision of sequential chemoradiation vs concurrent chemoradiation in locally advanced oropharyngeal carcinomas.

    abstract：PURPOSE:Induction chemotherapy has shown to provide consistent benefit for local control in primary treatment of advanced oropharyngeal cancer. The beneficial role of chemoradiation following induction chemotherapy over concurrent chemoradiation has not been evaluated. Present study evaluates the same prospectively. R...

    journal_title：Cancer biology & therapy

    pub_type： 杂志文章,随机对照试验

    doi：10.4161/cbt.8.3.7484

    authors： Gupta D,Shukla P,Bisht SS,Dhawan A,Pant MC,Bhatt ML,Gupta S,Gupta R,Negi MP

    更新日期：2009-02-01 00:00:00

  • ETS-TMPRSS2 fusion gene products in prostate cancer.

    abstract：:Genes playing a role in carcinogenesis have often been identified through analysis of recurrent chromosomal rearrangements. Although such rearrangements are well known in leukemias, lymphomas, and sarcomas, they have not been well characterized in carcinomas. In the October 28, 2005 issue of Science, a study by Tomlin...

    journal_title：Cancer biology & therapy

    pub_type： 杂志文章

    doi：10.4161/cbt.5.3.2603

    authors： Ahlers CM,Figg WD

    更新日期：2006-03-01 00:00:00

  • Epigenetic changes in gliomas.

    abstract：:Epigenetics are defined, in broad-terms, as alterations in gene expression without changes in DNA sequence. While histone modifications and DNA methylation are two classical means to regulate gene expression, miRNA has also recently been documented to govern gene expression in normal as well as cancer cells. In this r...

    journal_title：Cancer biology & therapy

    pub_type： 杂志文章,评审

    doi：10.4161/cbt.7.9.6992

    authors： Burgess R,Jenkins R,Zhang Z

    更新日期：2008-09-01 00:00:00

  • Histone, H1.2: another housekeeping protein that kills.

    abstract：:Histone H1.2, a housekeeping protein that binds nucleosomal linkers, has recently been identified as an apoptogenic factor released from the nucleus to the cytosol in response to double strand DNA breaks. In the cytosol, it promotes the activation of proapoptotic Bcl-2 family proteins, mitochondrial cytochrome c relea...

    journal_title：Cancer biology & therapy

    pub_type： 杂志文章

    doi：10.4161/cbt.3.1.738

    authors： Zong WX

    更新日期：2004-01-01 00:00:00

  • Drug-induced inactivation or gene silencing of class I histone deacetylases suppresses ovarian cancer cell growth: implications for therapy.

    abstract：:There is an urgent need to develop new strategies to treat ovarian cancer, the most deadly gynecologic malignancy. Histone deacetylase (HDAC) inhibitors are emerging as novel therapeutic drugs in the treatment of a variety of cancers, including those resistant to standard chemotherapy. Since there are multiple HDAC is...

    journal_title：Cancer biology & therapy

    pub_type： 杂志文章

    doi：10.4161/cbt.6.5.4007

    authors： Khabele D,Son DS,Parl AK,Goldberg GL,Augenlicht LH,Mariadason JM,Rice VM

    更新日期：2007-05-01 00:00:00

  • IDO inhibits T-cell function through suppressing Vav1 expression and activation.

    abstract：PURPOSE:Indoleamine 2,3-dioxygenase (IDO), a tryptophan catabolic enzyme, plays an important role in immune escape through suppressing T-cell function. Since Vav1 signaling pathway regulates T cell homeostasis, this study was designed to test the hypothesis that IDO induces T-cell immunosuppression through inhibiting V...

    journal_title：Cancer biology & therapy

    pub_type： 杂志文章

    doi：10.4161/cbt.8.14.8882

    authors： Li R,Wei F,Yu J,Li H,Ren X,Hao X

    更新日期：2009-07-01 00:00:00

  • Sorafenib and pemetrexed toxicity in cancer cells is mediated via SRC-ERK signaling.

    abstract：:The present studies sought to further understand how the anti-folate pemetrexed and the multi-kinase inhibitor sorafenib interact to kill tumor cells. Sorafenib activated SRC, and via SRC the drug combination activated ERK1/2. Expression of dominant negative SRC or dominant negative MEK1 abolished drug-induced ERK1/2 ...

    journal_title：Cancer biology & therapy

    pub_type： 杂志文章

    doi：10.4161/cbt.20562

    authors： Bareford MD,Hamed HA,Allegood J,Cruickshanks N,Poklepovic A,Park MA,Ogretmen B,Spiegel S,Grant S,Dent P

    更新日期：2012-07-01 00:00:00

  • Mutant TNFalpha negatively regulates human breast cancer stem cells from MCF7 in vitro.

    abstract：:Understanding the biology of breast cancer stem cells and trying new ways to obliterate these cells would be a key step in developing cures for breast cancer. The objective of this study was to investigate the effect of mutant TNFalpha on human breast cancer stem cells derived from MCF7 cell line under the characteriz...

    journal_title：Cancer biology & therapy

    pub_type： 杂志文章

    doi：10.4161/cbt.6.9.4885

    authors： Li Y,Kong L,Yang Y,Li K

    更新日期：2007-09-01 00:00:00

  • Tumor suppressor activities of the Fbw7 E3 ubiquitin ligase receptor.

    abstract：:The F-box protein Fbw7/Sel-10/hCdc4/Ago, which is known to regulate ubiquitination and degradation of numerous important regulators of cell division and death including Notch, cyclin E, c-Jun and c-Myc, has been recently rediscovered as a p53-dependent tumor suppressor. Delineation of the mechanisms of Fbw7 anti-oncog...

    journal_title：Cancer biology & therapy

    pub_type： 杂志文章,评审

    doi：10.4161/cbt.4.5.1703

    authors： Fuchs SY

    更新日期：2005-05-01 00:00:00

  • Harmine suppresses homologous recombination repair and inhibits proliferation of hepatoma cells.

    abstract：:To avoid cell cycle arrest or apoptosis, rapidly proliferating cancer cells have to promote DNA double strand break (DSB) repair to fix replication stress induced DSBs. Therefore, developing drugs blocking homologous recombination (HR) and nonhomologous end joining (NHEJ) - 2 major DSB repair pathways - holds great po...

    journal_title：Cancer biology & therapy

    pub_type： 杂志文章

    doi：10.1080/15384047.2015.1078021

    authors： Zhang L,Zhang F,Zhang W,Chen L,Gao N,Men Y,Xu X,Jiang Y

    更新日期：2015-01-01 00:00:00

  • The VEGFR-2 protein and the VEGFR-2 rs1870377 A>T genetic polymorphism are prognostic factors for gastric cancer.

    abstract：OBJECTIVE:Angiogenesis is one of the key processes in the development of malignant tumors. The vascular endothelial growth factor (VEGF) and VEGF receptor-2 (VEGFR-2) signaling pathway regulates branching angiogenesis in cancer. In this study, we analyzed the associations of VEGF/VEGFR-2 proteins and VEGFR-2 genetic va...

    journal_title：Cancer biology & therapy

    pub_type： 杂志文章

    doi：10.1080/15384047.2018.1537575

    authors： Zhu X,Wang Y,Xue W,Wang R,Wang L,Zhu ML,Zheng L

    更新日期：2019-01-01 00:00:00

  • Analysis of chromosomes 9 and 11 aneuploidy frequency in pleural effusion of patients with and without malignancy: interphase FISH technique.

    abstract：:Fluids of body cavities result in a series of pathophysiological events associated with non-malignant and malignant conditions that lead to the formation of exudative effusion. Diagnosis of effusion from the patients is frequently troublesome for the cytologist because of the differentiation and biological behavior of...

    journal_title：Cancer biology & therapy

    pub_type： 杂志文章

    doi：10.4161/cbt.4.2.1573

    authors： Cora T,Acar H,Ceran S,Bodur S

    更新日期：2005-02-01 00:00:00

  • Gemcitabine resistant pancreatic cancer cell lines acquire an invasive phenotype with collateral hypersensitivity to histone deacetylase inhibitors.

    abstract：:Gemcitabine based treatment is currently a standard first line treatment for patients with advanced pancreatic cancer, however overall survival remains poor, and few options are available for patients that fail gemcitabine based therapy. To identify potential molecular targets in gemcitabine refractory pancreatic canc...

    journal_title：Cancer biology & therapy

    pub_type： 杂志文章

    doi：10.4161/15384047.2014.986967

    authors： Samulitis BK,Pond KW,Pond E,Cress AE,Patel H,Wisner L,Patel C,Dorr RT,Landowski TH

    更新日期：2015-01-01 00:00:00